{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:03:59Z","timestamp":1790370239164,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010327","name":"Cincinnati Children\u2019s Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.mucimm.2026.100404","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:31:31Z","timestamp":1789745491000},"page":"100404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Loss of kallikrein 5 expression exacerbates allergic skin inflammation including impairing filaggrin processing, promoting Th2 differentiation and inducing dysbiosis"],"prefix":"10.1016","author":[{"given":"Andrea M.","family":"Klingler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybele","family":"Vidyant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santoshi","family":"Pyakurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenyatta C.M.F.","family":"Viel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yrina","family":"Rochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierra S.","family":"Beach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalen","family":"Rossey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brusilovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc E.","family":"Rothenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurit P.","family":"Azouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mucimm.2026.100404_bb0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2019.07.074","article-title":"Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study","volume":"82","author":"Deleuran","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.mucimm.2026.100404_bb0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jaad.2022.04.009","article-title":"Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)","volume":"87","author":"Shi","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.mucimm.2026.100404_bb0015","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/1744666X.2022.2060822","article-title":"The suitability of treating atopic dermatitis with Janus kinase inhibitors","volume":"18","author":"Narla","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"issue":"12","key":"10.1016\/j.mucimm.2026.100404_bb0020","doi-asserted-by":"crossref","first-page":"e1056","DOI":"10.1111\/jdv.70009","article-title":"Efficacy and safety of lebrikizumab in atopic dermatitis over 24 weeks: an analysis from the BIOREP registry","volume":"39","author":"Rob","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"16","key":"10.1016\/j.mucimm.2026.100404_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14165727","article-title":"Real-world clinical practice evaluation of Tralokinumab in atopic dermatitis: a 52-week multi-center retrospective study in the Basque Country","volume":"14","author":"Izu Belloso","year":"2025","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.mucimm.2026.100404_bb0030","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.178258","article-title":"Filaggrin loss-of-function variants are associated with atopic dermatitis phenotypes in a diverse, early-life prospective cohort","volume":"9","author":"Virolainen","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.mucimm.2026.100404_bb0035","doi-asserted-by":"crossref","unstructured":"McLean WH. Filaggrin failure - from ichthyosis vulgaris to atopic eczema and beyond. Br J Dermatol 2016; 175(Suppl Suppl 2): 4\u20137.","DOI":"10.1111\/bjd.14997"},{"issue":"6","key":"10.1016\/j.mucimm.2026.100404_bb0040","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/jdv.14172","article-title":"Filaggrin loss-of-function mutations, atopic dermatitis and risk of actinic keratosis: results from two cross-sectional studies","volume":"31","author":"Andersen","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.mucimm.2026.100404_bb0045","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jaci.2015.11.040","article-title":"Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells","volume":"138","author":"Leitch","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.mucimm.2026.100404_bb0050","article-title":"Skin barrier dysfunction in chronic dermatoses: from pathophysiology to emerging therapeutic strategies","volume":"17","author":"Espinoza Urzua","year":"2025","journal-title":"Cureus"},{"issue":"3 Pt 2","key":"10.1016\/j.mucimm.2026.100404_bb0055","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/jid.2011.393","article-title":"One remarkable molecule: filaggrin","volume":"132","author":"Brown","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"325","key":"10.1016\/j.mucimm.2026.100404_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad6833","article-title":"Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase","volume":"8","author":"Jarrett","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mucimm.2026.100404_bb0065","first-page":"1054","article-title":"Integrating outside modules into the i2b2 architecture","author":"Mendis","year":"2008","journal-title":"AMIA Annu Symp Proc"},{"issue":"3","key":"10.1016\/j.mucimm.2026.100404_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030913","article-title":"Multifaceted analyses of epidermal serine protease activity in patients with atopic dermatitis","volume":"21","author":"Nomura","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.mucimm.2026.100404_bb0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.alit.2024.08.010","article-title":"Cytokine profile of the stratum corneum in atopic dermatitis lesions differs between the face and the trunk","volume":"74","author":"Kido-Nakahara","year":"2025","journal-title":"Allergol Int"},{"issue":"3","key":"10.1016\/j.mucimm.2026.100404_bb0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1084\/jem.20131797","article-title":"Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome","volume":"211","author":"Furio","year":"2014","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.mucimm.2026.100404_bb0085","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20082242","article-title":"Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome","volume":"206","author":"Briot","year":"2009","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.mucimm.2026.100404_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/exd.70055","article-title":"Chemical suppression of KLK5 and KLK7 rescues barrier integrity in a Netherton syndrome model","volume":"34","author":"Yeo","year":"2025","journal-title":"Exp Dermatol"},{"issue":"675","key":"10.1016\/j.mucimm.2026.100404_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abp9159","article-title":"Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis","volume":"14","author":"Chavarria-Smith","year":"2022","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.mucimm.2026.100404_bb0100","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10875-021-01195-0","article-title":"Cocktails of KLK5 protease inhibitors and anti-TNFalpha therapeutics: an effective treatment for Netherton syndrome","volume":"42","author":"Zingkou","year":"2022","journal-title":"J Clin Immunol"},{"issue":"9","key":"10.1016\/j.mucimm.2026.100404_bb0105","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.jid.2021.01.029","article-title":"A potent and selective Kallikrein-5 inhibitor delivers high pharmacological activity in skin from patients with Netherton syndrome","volume":"141","author":"Liddle","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.mucimm.2026.100404_bb0110","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1515\/cclm-2019-0123","article-title":"Screening of chemical libraries in pursuit of kallikrein-5 specific inhibitors for the treatment of inflammatory dermatoses","volume":"57","author":"Di Paolo","year":"2019","journal-title":"Clin Chem Lab Med"},{"issue":"Pt 5","key":"10.1016\/j.mucimm.2026.100404_bb0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1107\/S2053230X19003169","article-title":"Evaluation of a crystallographic surrogate for kallikrein 5 in the discovery of novel inhibitors for Netherton syndrome","volume":"75","author":"Thorpe","year":"2019","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"issue":"12","key":"10.1016\/j.mucimm.2026.100404_bb0120","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.bmcl.2019.04.022","article-title":"Structure guided drug design to develop kallikrein 5 inhibitors to treat Netherton syndrome","volume":"29","author":"Walker","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"issue":"545","key":"10.1016\/j.mucimm.2026.100404_bb0125","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1126\/scitranslmed.aaz7773","article-title":"Functional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis","volume":"12","author":"Azouz","year":"2020","journal-title":"Sci Transl Med"},{"issue":"31","key":"10.1016\/j.mucimm.2026.100404_bb0130","doi-asserted-by":"crossref","first-page":"11736","DOI":"10.1073\/pnas.0604575103","article-title":"Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis","volume":"103","author":"Li","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mucimm.2026.100404_bb0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-4939-6786-5_8","article-title":"A mouse model for atopic dermatitis using topical application of vitamin D3 or of its analog MC903","volume":"1559","author":"Moosbrugger-Martinz","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.mucimm.2026.100404_bb0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/jidsymp.2011.4","article-title":"Rosacea as a disease of cathelicidins and skin innate immunity","volume":"15","author":"Yamasaki","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"8","key":"10.1016\/j.mucimm.2026.100404_bb0145","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/ismej.2012.8","article-title":"Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms","volume":"6","author":"Caporaso","year":"2012","journal-title":"ISME J"},{"issue":"8","key":"10.1016\/j.mucimm.2026.100404_bb0150","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/nprot.2014.134","article-title":"Generating genetically modified mice using CRISPR\/Cas-mediated genome engineering","volume":"9","author":"Yang","year":"2014","journal-title":"Nat Protoc"},{"issue":"8","key":"10.1016\/j.mucimm.2026.100404_bb0155","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/jgh.14536","article-title":"Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats","volume":"34","author":"Zhang","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.mucimm.2026.100404_bb0160","article-title":"Lachnospiraceae are emerging industrial biocatalysts and biotherapeutics","volume":"11","author":"Zaplana","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"10.1016\/j.mucimm.2026.100404_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1907272","article-title":"Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease","volume":"13","author":"Stoeva","year":"2021","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.mucimm.2026.100404_bb0170","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ismej.2012.158","article-title":"Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model","volume":"7","author":"Van den Abbeele","year":"2013","journal-title":"ISME J"},{"issue":"6","key":"10.1016\/j.mucimm.2026.100404_bb0175","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1111\/1751-7915.13779","article-title":"Butyrate production in the acetogen Eubacterium limosum is dependent on the carbon and energy source","volume":"14","author":"Litty","year":"2021","journal-title":"J Microbial Biotechnol"},{"issue":"5","key":"10.1016\/j.mucimm.2026.100404_bb0180","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/all.14625","article-title":"Butyrate as a bioactive human milk protective component against food allergy","volume":"76","author":"Paparo","year":"2021","journal-title":"Allergy"},{"issue":"7480","key":"10.1016\/j.mucimm.2026.100404_bb0185","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mucimm.2026.100404_bb0190","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/gbe\/evu050","article-title":"A phylogenomic view of ecological specialization in the Lachnospiraceae, a family of digestive tract-associated bacteria","volume":"6","author":"Meehan","year":"2014","journal-title":"Genome Biol Evol"},{"issue":"4","key":"10.1016\/j.mucimm.2026.100404_bb0195","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jid.2016.11.014","article-title":"The short-chain fatty acid sodium butyrate functions as a regulator of the skin immune system","volume":"137","author":"Schwarz","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.mucimm.2026.100404_bb0200","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2017.08.028","article-title":"Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases","volume":"153","author":"Nikolaus","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mucimm.2026.100404_bb0205","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.2147\/JIR.S300989","article-title":"The immunomodulatory functions of butyrate","volume":"14","author":"Siddiqui","year":"2021","journal-title":"J Inflamm Res"},{"issue":"2","key":"10.1016\/j.mucimm.2026.100404_bb0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clnu.2022.10.024","article-title":"Butyrate\u2019s role in human health and the current progress towards its clinical application to treat gastrointestinal disease","volume":"42","author":"Hodgkinson","year":"2023","journal-title":"Clin Nutr"},{"issue":"8","key":"10.1016\/j.mucimm.2026.100404_bb0215","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jgg.2012.05.008","article-title":"Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth","volume":"39","author":"Wu","year":"2012","journal-title":"J Genet Genomics"},{"issue":"27","key":"10.1016\/j.mucimm.2026.100404_bb0220","doi-asserted-by":"crossref","first-page":"42826","DOI":"10.18632\/oncotarget.8753","article-title":"GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-beta releasing","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.mucimm.2026.100404_bb0225","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jid.2020.01.012","article-title":"PAR2 mediates itch via TRPV3 signaling in keratinocytes","volume":"140","author":"Zhao","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.mucimm.2026.100404_bb0230","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jid.2019.10.022","article-title":"Kallikrein 7 promotes atopic dermatitis-associated itch independently of skin inflammation","volume":"140","author":"Guo","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.mucimm.2026.100404_bb0235","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jaci.2017.01.025","article-title":"Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity","volume":"140","author":"Zhu","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mucimm.2026.100404_bb0240","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2022.06.004","article-title":"Aberrant serine protease activities in atopic dermatitis","volume":"107","author":"Morizane","year":"2022","journal-title":"J Dermatol Sci"},{"issue":"2","key":"10.1016\/j.mucimm.2026.100404_bb0245","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jdermsci.2019.06.007","article-title":"Physiological and pathological roles of kallikrein-related peptidases in the epidermis","volume":"95","author":"Kishibe","year":"2019","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.mucimm.2026.100404_bb0250","doi-asserted-by":"crossref","unstructured":"Kim JH, Bae HC, Ko NY, Lee SH, Jeong SH, Lee H et al. Thymic stromal lymphopoietin downregulates filaggrin expression by signal transducer and activator of transcription 3 (STAT3) and extracellular signal-regulated kinase (ERK) phosphorylation in keratinocytes. J Allergy Clin Immunol 2015; 136(1): 205\u2013208 e209.","DOI":"10.1016\/j.jaci.2015.04.026"},{"issue":"5","key":"10.1016\/j.mucimm.2026.100404_bb0255","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jaci.2020.10.006","article-title":"Dual function of Langerhans cells in skin TSLP-promoted T(FH) differentiation in mouse atopic dermatitis","volume":"147","author":"Marschall","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mucimm.2026.100404_bb0260","doi-asserted-by":"crossref","unstructured":"Nakajima S, Igyarto BZ, Honda T, Egawa G, Otsuka A, Hara-Chikuma M et al. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol 2012; 129(4): 1048\u20131055 e1046.","DOI":"10.1016\/j.jaci.2012.01.063"},{"issue":"12","key":"10.1016\/j.mucimm.2026.100404_bb0265","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.204687","article-title":"IL-13 and calpain-14 suppress the expression of SPINK7 by regulating OVOL1 in eosinophilic esophagitis","volume":"11","author":"Azouz","year":"2026","journal-title":"JCI Insight"},{"issue":"29","key":"10.1016\/j.mucimm.2026.100404_bb0270","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.2174\/0113816128258924231011103813","article-title":"Alphanti-KLK5\/KLK7 antibody-based strategies for the treatment of epidermal diseases","volume":"29","author":"Pampalakis","year":"2023","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.mucimm.2026.100404_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006566","article-title":"KLK5 and KLK7 ablation fully rescues lethality of Netherton syndrome-like phenotype","volume":"13","author":"Kasparek","year":"2017","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.mucimm.2026.100404_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408363.2020.1775171","article-title":"The role of kallikreins in inflammatory skin disorders and their potential as therapeutic targets","volume":"58","author":"Di Paolo","year":"2021","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"6","key":"10.1016\/j.mucimm.2026.100404_bb0285","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/bjd.12219","article-title":"Ichthyosis vulgaris: the filaggrin mutation disease","volume":"168","author":"Thyssen","year":"2013","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.mucimm.2026.100404_bb0290","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/ng.2438","article-title":"Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population","volume":"44","author":"Hirota","year":"2012","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.mucimm.2026.100404_bb0295","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.clindermatol.2017.03.006","article-title":"Current and emerging concepts in atopic dermatitis pathogenesis","volume":"35","author":"Sullivan","year":"2017","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.mucimm.2026.100404_bb0300","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.1302454","article-title":"Demethylation of the human eotaxin-3 gene promoter leads to the elevated expression of eotaxin-3","volume":"192","author":"Lim","year":"2014","journal-title":"J Immunol"},{"issue":"15","key":"10.1016\/j.mucimm.2026.100404_bb0305","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1074\/jbc.M110.210724","article-title":"Epigenetic regulation of the IL-13-induced human eotaxin-3 gene by CREB-binding protein-mediated histone 3 acetylation","volume":"286","author":"Lim","year":"2011","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.mucimm.2026.100404_bb0310","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1515\/BC.2008.171","article-title":"Role of tissue kallikrein-related peptidases in cervical mucus remodeling and host defense","volume":"389","author":"Shaw","year":"2008","journal-title":"Biol Chem"},{"issue":"12","key":"10.1016\/j.mucimm.2026.100404_bb0315","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1096\/fj.06-6075com","article-title":"Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin","volume":"20","author":"Yamasaki","year":"2006","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.mucimm.2026.100404_bb0320","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000453594","article-title":"Transmembrane mucins: signaling receptors at the intersection of inflammation and Cancer","volume":"9","author":"van Putten","year":"2017","journal-title":"J Innate Immun"},{"issue":"7461","key":"10.1016\/j.mucimm.2026.100404_bb0325","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12331","article-title":"Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota","volume":"500","author":"Atarashi","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.mucimm.2026.100404_bb0330","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1172\/JCI125917","article-title":"Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis","volume":"129","author":"Wen","year":"2019","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.mucimm.2026.100404_bb0335","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.immuni.2015.02.004","article-title":"Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy","volume":"42","author":"Noval Rivas","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.mucimm.2026.100404_bb0340","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jphotobiol.2004.09.004","article-title":"Combined dermal exposure to permethrin and cis-urocanic acid suppresses the contact hypersensitivity response in C57BL\/6N mice in an additive manner","volume":"78","author":"Prater","year":"2005","journal-title":"J Photochem Photobiol B"},{"issue":"6","key":"10.1016\/j.mucimm.2026.100404_bb0345","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0781.2010.00550.x","article-title":"Urocanic acid suppresses induction of immunity in human skin","volume":"26","author":"Dahl","year":"2010","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"46","key":"10.1016\/j.mucimm.2026.100404_bb0350","doi-asserted-by":"crossref","first-page":"17420","DOI":"10.1073\/pnas.0603119103","article-title":"Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor","volume":"103","author":"Walterscheid","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.mucimm.2026.100404_bb0355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/iovs.61.4.7","article-title":"UV-B-induced Inflammasome activation can be prevented by Cis-Urocanic acid in human corneal epithelial cells","volume":"61","author":"Korhonen","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.mucimm.2026.100404_bb0360","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/jid.2012.18","article-title":"Kallikrein-related peptidase 8-dependent skin wound healing is associated with upregulation of kallikrein-related peptidase 6 and PAR2","volume":"132","author":"Kishibe","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.mucimm.2026.100404_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005389","article-title":"KLK5 inactivation reverses cutaneous hallmarks of Netherton syndrome","volume":"11","author":"Furio","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.mucimm.2026.100404_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbplus.2019.100019","article-title":"Kallikreins: essential epidermal messengers for regulation of the skin microenvironment during homeostasis, repair and disease","volume":"6-7","author":"Nauroy","year":"2020","journal-title":"Matrix Biol Plus"},{"issue":"17","key":"10.1016\/j.mucimm.2026.100404_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26178605","article-title":"Deletion of the epidermal protease KLK5 aggravates the symptoms of congenital ichthyosis CDSN-nEDD","volume":"26","author":"Zingkou","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.mucimm.2026.100404_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.07.014","article-title":"Elimination of KLK5 inhibits early skin tumorigenesis by reducing epidermal proteolysis and reinforcing epidermal microstructure","volume":"1865","author":"Pampalakis","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"9","key":"10.1016\/j.mucimm.2026.100404_bb0385","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1515\/hsz-2014-0137","article-title":"Netherton syndrome: defective kallikrein inhibition in the skin leads to skin inflammation and allergy","volume":"395","author":"Furio","year":"2014","journal-title":"Biol Chem"},{"issue":"6","key":"10.1016\/j.mucimm.2026.100404_bb0390","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1600-0625.2007.00562.x","article-title":"Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients","volume":"16","author":"Komatsu","year":"2007","journal-title":"Exp Dermatol"},{"issue":"12","key":"10.1016\/j.mucimm.2026.100404_bb0395","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/exd.14201","article-title":"Topical doxycycline monohydrate hydrogel 1% targeting proteases\/PAR2 pathway is a novel therapeutic for atopic dermatitis","volume":"29","author":"Bohannon","year":"2020","journal-title":"Exp Dermatol"}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021926001066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021926001066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:36:02Z","timestamp":1790368562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021926001066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":79,"alternative-id":["S1933021926001066"],"URL":"https:\/\/doi.org\/10.1016\/j.mucimm.2026.100404","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of kallikrein 5 expression exacerbates allergic skin inflammation including impairing filaggrin processing, promoting Th2 differentiation and inducing dysbiosis","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mucimm.2026.100404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Society for Mucosal Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100404"}}